Cell line modeling to study biomarker panel in prostate cancer

Area of Science:

• Oncology
• Genetics
• Cell Biology

Background:

• Prostate cancer (PCa) exhibits higher grade and stage in African-American men compared to Caucasians.
• A biological basis for this disparity is suspected, but well-characterized experimental models are lacking.
• This study introduces a novel in vitro cell line model to address this gap.

Purpose of the Study:

• To develop and validate an in vitro cell line model system for studying the biological basis of racial disparities in prostate cancer.
• To explore the utility of this model in investigating variations in malignant phenotypes.
• To demonstrate the model's applicability in functional studies relevant to PCa progression.

Main Methods:

• Assembled a PCa cell line model including African-American and Caucasian (LNCaP, C4-2) cell lines.
• Utilized a multiplex biomarker panel (Western blot, RT-PCR) to assess protein expression.
• Validated biomarker expression in human PCa tissues and performed functional assays (MTS viability, molecular studies).

Main Results:

• The African-American cell line (E006AA) showed biomarker dysregulation similar to metastatic Caucasian cell lines, suggesting an aggressive phenotype.
• Overexpression of Protein kinase D1 (PKD1) decreased proliferation and epithelial mesenchymal transition (EMT).
• Feasibility of studying biomarker expression in archived human PCa tissues was established.

Conclusions:

• A novel in vitro cell line model for prostate cancer (PCa) has been characterized.
• This model can be utilized to investigate the biological underpinnings of PCa disparity between African-Americans and Caucasians.
• The model facilitates future translational studies on PCa progression and racial differences.